Predictors of mortality in patients with an implantable cardiac defibrillator: A systematic review and meta-analysis

Canadian Journal of Cardiology

Volumn 29, Issue 12, 2013, Pages 1729-1740

  Alba, Ana C ^a   Braga, Juarez ^a   Gewarges, Mena ^a   Walter, Stephen D ^b   Guyatt, Gordon H ^b   Ross, Heather J ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR MORTALITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DISEASE ASSOCIATION; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; META ANALYSIS; NEW YORK HEART ASSOCIATION CLASS; PERIPHERAL VASCULAR DISEASE; PREDICTIVE VALUE; REVIEW; SEX DIFFERENTIATION; SYSTEMATIC REVIEW;

AGED; CAUSE OF DEATH; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RISK FACTORS;

EID: 84888210460     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2013.09.024     Document Type: Review

References (25)

1. Rosamond W., Flegal K., Furie K., et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2008 Update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008, 117:E25-E146.
2. Bleumink G.S., Knetsch A.M., Sturkenboom M.C., et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure: The Rotterdam Study. Eur Heart J 2004, 25:1614-1619.
3. Jessup M., Abraham W.T., Casey D.E., et al. 2009 Focus Update: ACC/AHA guidelines for the diagnosis and management of heart failure in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009, 119:1977-2016.
4. Vardas P., Auricchio A., Blanc J.J., European Society of Cardiology, European Heart Rhythm Association, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy. Europace 2007, 9:959-998.
5. McMurray J.J., Adamopoulos S., Anker S.D., et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA). Eur Heart J 2012, 33:1787-1847.
6. Camm J., Nisam S. European utilization of the implantable defibrillator: has 10 years changed the 'enigma'?. Europace 2010, 12:1063-1069.
7. Greenberg S., Epstein A., Deering T., et al. Acomparison of ICD implantations in the United States versus Italy. Pacing Clin Electrophysiol 2007, 30:S143-S146.
8. Alba A.C., Agoritsas T., Jankowski M., et al. Risk prediction models for mortality in ambulatory heart failure patients: a systematic review. Circ Heart Fail 2013, 6:881-889.
9. Moons K.G., Kengne A.P., Woodward M., et al. Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio) marker. Heart 2012, 98:683-690.
10. Peduzzi P., Concato J., Feinsten A.R., Holford T.R. Importance of events per independent variable in proportional hazards regression analysis II. Accuracy and precision of regression estimates. JClin Epidemiol 1995, 48:1503-1510.
11. Deeks JJ, Higgins JP, Altman DG, on behalf of the Cochrane Statistical Methods Group, eds. Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at: Accessed February 20, 2013. http://www.cochranehandbook.org.
12. Exner D.V, Pinski S.L., Wyse D.G., et al. Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation 2001, 103:2066-2071.
13. Arshad A, Moss A.J., Foster E., Padeletti L., et al. MADIT-CRT Executive Committee. Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. J Am Coll Cardiol 2011, 57:813-820.
14. Cygankiewicz I, Gillespie J., Zareba W., et al. Predictors of long-term mortality in multicenter automatic defibrillator implantation trial II (MADIT II) patients with implantable cardioverter-defibrillators. Heart Rhythm 2009, 6:468-473.
15. Concato J., Feinstein A.R., Holford T.R. The risk of determining risk of multivariable models. Ann Intern Med 1993, 118:201-210.
16. Kramer D.B., Friedman P.A., Kallinen L.M., et al. Development and validation of a risk score to predict early mortality in recipients of an implantable cardioverter-defibrillator. Heart Rhythm 2012, 9:42-46.
17. Bilchick K.C., Stukenborg G.J., Kamath S., Cheng A. Prediction of mortality in clinical practice for Medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death. JAm Coll Cardiol 2012, 60:1647-1655.
18. Levy W.C., Lee K.L., Hellkamp A.S., et al. Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in heart failure population. Circulation 2009, 120:835-842.
19. Smith T., Levy W.C., Schaer B.A., et al. Performance of the Seattle Heart Failure Model in implantable defibrillator patients treated with cardiac resynchronization therapy. Am J Cardiol 2012, 110:398-402.
20. Clemens M., Szegedi Z., Kardos L., et al. The Seattle Heart Failure Model predicts survival in patients with cardiac resynchronization therapy: a validation study. JCard Fail 2012, 18:682-687.
21. Regoli F., Scopigni F., Leyva F., et al. Validation of the Seattle Heart Failure Model for mortality risk prediction in patients treated with cardiac resynchronization therapy. Eur J Heart Fail 2013, 15:211-220.
22. Singh T.P., Almond C.S., Taylor D.O., Graham D.A. Decline in heart transplant wait list mortality in the United States following broader regional sharing of donor hearts. Circ Heart Fail 2012, 5:249-258.
23. Goda A., Lund L.H., Mancini D. The Heart Failure Survival Score outperforms the peak oxygen consumption for heart transplantation selection in the era of device therapy. JHeart Lung Transplant 2011, 30:315-325.
24. Mehra M.R., Kobashigawa J., Starling R., et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation Guidelines for the care of cardiac transplant candidates-2006. JHeart Lung Transplant 2006, 25:1024-1042.
25. Mitar M., Alba A.C., MacIver J., Ross H. Lost in translation. Examining patient and physician perceptions of implantable cardioverter-defibrillator deactivation discussions. Circ Heart Fail 2012, 5:660-666.